Module A-2 Flashcards
Kinetic vs dynamic vs biophase figure
Figure relating pH and PKa
Pre-systemic elimination
Elimination by GI system before it can get to systemic circulation
-stomach acids hydrolyze drug
-enzymes from GI wall deactivate drug
-liver bio transforms drug before it reaches effect site
Properties impacting kinetics
-molecular size
-drug transporters
-degree ionization
-lipid solubility
Properties impacting kinetics
-molecular size
-drug transporters
-degree ionization
-lipid solubility
Key points of Oral
-Degree of ionization impacts absorption
-low bioavailability
-liver first pass
pKa
pH at which drug will be 50% ionized and non-ionized
Characteristics of non-ionized drugs
-lipid soluble
-hepatic metabolism
-no renal excretion
Characteristics of ionized drugs
-water soluble
-renal excretion
-do not cross lipid barriers
Bioavailability
Extent to which drug reaches effector site
-solubility (lipids vs aqueous)
-molecular weight
-pH
-pKa
-perfusion/blood flow to effector site
Ion trapping
Non-ionized drugs cross a lipid barrier and become ionized on the other side due to a change in pH and cannot cross back over-can quickly lead to toxicity
Two compartment model
Drug is first distributed to the vessel rich group (central compartment) and then redistributed to the the peripheral compartment or metabolized/excreted
Volume of distribution
Apparent volume in which drug has been distributed after it has been introduced
Variables:
-drug size
-carrier molecules
-disease states (burns, liver disease, pregnancy)
-solubility
Large Vd (>0.67 L/kg)
Widely distributed, likely lipophilic- think propofol
Small Vd (<0.4 L/kg)
Likely stays in plasma, highly hydrophilic, rocuronium
Oxidation
Loss of an electron
Reduction
Gain of an electron